BioSpyder Expands Presence in Southeast Asia Through Distribution Partnership with Atlantis Bioscience

CARLSBAD, Calif. — June 29th 2026— BioSpyder Technologies, Inc. is pleased to announce its continued expansion into Southeast Asia through its distribution partnership with Atlantis Bioscience, a Singapore-based life science supplier supporting researchers across Singapore, Malaysia, and the broader regional biomedical research community.

TempO-Seq enables high-throughput targeted gene expression profiling with simplified workflows, scalable sample processing, and broad applicability across toxicology, drug discovery, environmental health, oncology, translational research, and other areas of biomedical science. By working with Atlantis Bioscience, BioSpyder aims to support researchers in Singapore and Malaysia seeking practical alternatives to traditional RNA sequencing for large sample studies, screening applications, and targeted molecular profiling.

The partnership is part of BioSpyder’s broader commercial strategy to expand its global distribution network and strengthen access to TempO-Seq in key international research markets. Singapore and Malaysia represent important life science markets in Southeast Asia, with strong research activity across pharmaceutical development, biotechnology, genomics, precision medicine, and translational science.

“Singapore and Malaysia are important and growing life science markets, and we are excited to work with Atlantis Bioscience to support researchers across the region,” said Garrett McComb, Director of BioSpyder Technologies. “This partnership helps expand access to TempO-Seq for organizations seeking scalable, cost-effective gene expression profiling across a wide range of research applications.”

For more information about TempO-Seq and BioSpyder’s innovative technologies, please visit www.biospyder.com.